Drug Database
Back to search

Netherlands· NL-a609cd24f95c

Marcoumar 3 mg tabletten

A phenprocoumon product containing fenprocoumon, registered in Netherlands by Viatris Healthcare B.V.. The same ATC class is registered in 7 of our 19 countries.

ATC B01AA04

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedMarcoumar 3 mg tablettenATCB01AA04REGISTER NO.NL-a609cd24f95cPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about fenprocoumonAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Phenprocoumon is registered in 7 of 19 countries.

Countries holding a registration under ATC B01AA04 (phenprocoumon), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 3 of them publish a price we can compare per daily dose
Search phenprocoumon products by name

Phenprocoumon · ATC B01AA04

7 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Germany
  • Netherlands
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of phenprocoumon costs, country by country.

Normalised to the WHO defined daily dose (3 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Phenprocoumon · price per daily dose (3 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.45
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
FENPROCOUMON
Manufacturer
Viatris Healthcare B.V.
Country
Netherlands (NL)
ATC code
B01AA04
ATC class
Phenprocoumon
Defined daily dose
3 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    03819

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

82 interactions on record for phenprocoumon.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check phenprocoumon against other medicinesHow interaction checks work

Phenprocoumon · interactions on record

82 records

82 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Phenprocoumon in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All phenprocoumon products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • Austria · Marcoumar
  • Belgium · Marcoumar
  • Germany · Falithrom, Marcumar
  • Luxembourg · Marcoumar

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f0a7add7-e22b-4988-84a9-a31917da6ade
GET /v1/drugs/f0a7add7-e22b-4988-84a9-a31917da6ade?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h03819_smpc.pdf",
  "strength": null,
  "atc_label": "Phenprocoumon",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg03819",
  "excipients": [
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL",
    "TALK (E 553b)"
  ],
  "substances": [
    "FENPROCOUMON"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h03819.pdf",
  "authorised_at": "1990/05/20",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "03819",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about phenprocoumon.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console